A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2002
11/26/2002	US6485704 Azo compound for type I pototherapy
11/26/2002	US6485703 Devices are implanted in, through, on or under the skin in order to measure these and other analytes in vivo
11/21/2002	WO2002093163A1 Test method for pain evaluation
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092550A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002	WO2002092108A1 Methods for assessing antiangiogenic agents
11/21/2002	WO2002091991A2 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use
11/21/2002	WO2002055089B1 Immunoassay technique using multispecific molecules
11/21/2002	WO2002024226A8 Photosensitisers
11/21/2002	US20020172762 Polymerization of the shell-shaping substance(s) and the build-up of microcapsules are carried out in each case while being stirred, but separately in time and/or space; gas-filled microcapsules have core-shell structure
11/21/2002	US20020172643 For use in diagnostic ultrasonic imaging
11/21/2002	US20020170860 Process for the purification of water-soluble non-ionic contrast agents
11/21/2002	CA2446747A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/20/2002	EP1257827A1 Diagnosis of breast cancer using bcmp-11 as marker
11/20/2002	EP1257563A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
11/20/2002	EP1257549A2 Matrix metalloproteinase inhibitors and uses thereof
11/20/2002	EP1257285A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
11/20/2002	EP1257268A2 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents
11/20/2002	EP1073472B1 Solution containing an ester of ala for diagnosing or treating tissue pathologies
11/20/2002	EP1017684B1 Contrasting agent for infarct and necrosis imaging
11/20/2002	EP0896546B1 Method of t1-weighted magnetic resonance imaging of res organs
11/20/2002	EP0880397B1 Apparatus and method for producing polarised vapour-phase helium-3, particularly for nmr imaging
11/20/2002	EP0711127B1 Methods of preparing gas-filled liposomes
11/19/2002	US6482518 Excipient for the lyophilization of aqueous suspensions of microparticles
11/19/2002	US6482517 Coated particles, methods of making and using
11/19/2002	US6482388 Combined body length in the selective breeding of thoroughbred racehorses
11/15/2002	WO2001087347A1 Heterobifunctional cross-linking agent conjugate substituted by an immunomodulator and cell recognition unit
11/15/2002	CA2409255A1 Heterobifunctional cross-linking agent conjugate substituted by an immunomodulator and cell recognition unit
11/14/2002	WO2002090981A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof
11/14/2002	WO2002089858A1 Azo compounds for type i phototherapy
11/14/2002	WO2002089794A1 Method for treating neuropathic pain and pharmaceutical preparation therefor
11/14/2002	WO2002089771A1 Liposomes
11/14/2002	WO2002049422A3 Non-human animal disease models
11/14/2002	WO2001024831A9 Polymer stabilized neuropeptides
11/14/2002	US20020169394 Integrated tissue poration, fluid harvesting and analysis device, and method therefor
11/14/2002	US20020169292 Human glycoprotein hormone for use in the prevention and treatment of metabolic and sexual disorders
11/14/2002	US20020168753 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
11/14/2002	US20020168419 Magnetic resonance imaging
11/14/2002	US20020168375 Biosynthetic binding proteins for immuno-targeting
11/14/2002	US20020168355 Cationic liposome delivery of taxanes to angiogenic blood vessels
11/14/2002	US20020168321 Comprising as dispersion in carrier liquid a positive contrast agent acting on T1 proton relaxation factor, and a negative contrast agent component acting on T2 proton relaxation factor, one remaining in blood longer than other
11/14/2002	US20020168320 Site specific binding system, imaging compositions and methods
11/14/2002	US20020168317 Catheter for in vivo detection of nuclear or fluorescent radiation emitted from tagged biological tissue within a human body
11/13/2002	EP1255993A2 Methods for identifying modulators for balance related disorders
11/13/2002	EP1255570A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
11/13/2002	EP1255499A2 Radiofrequency apparatus and method for accessing a biopsy site
11/13/2002	EP0966428B1 PROCESS FOR THE CRYSTALLIZATION FROM A LINEAR OR BRANCHED (C5-C6) ALCOHOL OR THEIR MIXTURES OF (S)-N,N'-bis 2-HYDROXY-1- (HYDROXYMETHYL)ETHYL]-5- (2-HYDROXY-1-OXOPROPYL)AMINO]-2,4,6- TRIIODO-1,3-BENZENEDICARBOXAMIDE
11/13/2002	EP0756496B1 Dendrimeric compounds
11/13/2002	CN1379687A Magnetic nanoparticles having biochemial activity, method for production thereof and their use
11/12/2002	US6479637 Hemoglobin-haptoglobin complexes
11/12/2002	US6479034 Method of preparing gas and gaseous precursor-filled microspheres
11/12/2002	US6479033 Antitumor cystostatic and contrast agent
11/12/2002	US6479032 Calcitonin receptor binding reagents
11/12/2002	US6478765 Apparatus for removing thrombosis
11/12/2002	US6478749 Diagnostic kit for skin tests, and method
11/12/2002	CA2195318C Iron-containing nanoparticles with double coating and their use in diagnosis and therapy
11/12/2002	CA2107108C Improvements in or relating to contrast agents
11/12/2002	CA2101227C Chlorophyll and bacteriochlorophyll derivatives and pharmaceutical compositions containing them
11/07/2002	WO2002088666A2 Method for identifying lymph nodes
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002087632A1 High throughput screening methods using magnetic resonance imaging agents
11/07/2002	WO2002087629A1 Ct scanner for imaging a preselected portion of a patient
11/07/2002	WO2002087628A1 In vivo method for measuring binding of chemical actives to skin or specific constituents of skin
11/07/2002	WO2002087500A2 Viral enzyme activated prototoxophores and use of same to treat viral infections
11/07/2002	WO2002087424A2 Treatment and diagnosis of macrophage mediated disease
11/07/2002	WO2002048119A3 Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof
11/07/2002	WO2002041870A3 Production and use of a targeted diagnostic system
11/07/2002	WO2001092300A3 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level
11/07/2002	US20020165122 Method and compositions for the treatment or amelioration of female sexual dysfunction
11/07/2002	US20020165118 Transgenic animal
11/07/2002	US20020164289 Medical diagnosis
11/07/2002	US20020164288 Fullerene (C60) -based X-ray contrast agent for diagnostic imaging
11/07/2002	US20020164287 Azo compounds for type i phototherapy
11/07/2002	US20020164286 Methods for obtaining fluid and cellular material from a breast duct
11/07/2002	US20020164285 Labeling skin; medical diagnosis
11/07/2002	DE10118792A1 Arrangement for taking mammograms comprises two X-ray anodes which respectively have emission energies below and above the absorption energy of the contrast enhancing agent
11/07/2002	CA2445826A1 Treatment and diagnosis of macrophage mediated disease
11/07/2002	CA2445338A1 G-protein coupled receptors
11/07/2002	CA2442659A1 In vivo method for measuring binding of chemical actives to skin or specific constituents of skin
11/06/2002	EP1254374A2 Method for diagnosing efficacy of xenotypic antibody therapy
11/06/2002	EP1254368A1 Method of cancer screening primarily utilizing non-invasive cell collection and fluorescence detection techniques
11/06/2002	EP1254179A1 An in vivo screen using chemical inducers of dimerization
11/06/2002	EP1253928A2 Novel haptotactic peptides
11/06/2002	EP1040168B1 Novel dye-polysaccharide-conjugates and the utilization thereof as a diagnostic
11/06/2002	EP0711300B1 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
11/06/2002	EP0623134B1 Metal complexes of water soluble texaphyrins
11/06/2002	CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002	CN1377881A Intermediate for preparing cascade polymeric ligand and contrast medium
11/06/2002	CN1093768C Diagnostic marker
11/05/2002	US6476213 Cloning and characterization of FLBA gene of H. pylori production of aflagellate
11/05/2002	US6475746 Method of obtaining a composition comprising a 5-HT1D selective compound
11/05/2002	US6475515 Contrast medium that is to be encapsulated in the liposomes is metered such that 5 to 95% by weight of the contrast medium is present in unencapsulated form stabilization
11/05/2002	US6475477 Radio-opaque polymer biomaterials
11/05/2002	CA2091449C Cloning and sequencing of allergens of dermatophagoides (house dust mite)
10/2002
10/31/2002	WO2002086472A1 Molecular rotor derivatives and methods of use
10/31/2002	WO2002086449A2 Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject
10/31/2002	WO2002085417A2 Methods and devices for moisturizing hyperpolarized noble gases and pharmaceutical products thereof
10/31/2002	WO2002085388A1 Ca2+/calmodulin-dependent protein kinase iv
10/31/2002	WO2002085325A2 Production and use of a suspension composition comprising an ultrasound contrast medium

1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 354